WAY-324887 is a selective 5-HT6 receptor antagonist that has been primarily investigated for its potential in treating cognitive and neurodegenerative disorders. It has shown promise in preclinical studies for improving memory and cognitive function, making it a candidate for research in conditions such as Alzheimer's disease. The compound crosses the blood-brain barrier effectively, allowing for central nervous system activity. Its mechanism involves modulating neurotransmitter systems involved in learning and memory, particularly through serotonin pathways. Due to its specificity, it has been used as a pharmacological tool to study 5-HT6 receptor function and validate this receptor as a therapeutic target in psychiatric and neurological diseases.